Barclays Maintains Equal-Weight on CME Group, Raises Price Target to $344

Benzinga Newsdesk www.benzinga.com Positive 75.4%

Neg 0% Neu 0% Pos 75.4%

Barclays analyst Benjamin Budish maintains CME Group (NASDAQ:CME) with a Equal-Weight and raises the price target from $312 to $344.